rs1341894581

Variant summary

Our verdict is Pathogenic. The variant received 16 ACMG points: 16P and 0B. PVS1PP5_Very_Strong

The NM_004826.4(ECEL1):​c.110_155delTCCCGTTGGGCGCTGCGCGCAGCGCCACCGGGGCCCGGTCCGGGCT​(p.Phe37CysfsTer151) variant causes a frameshift change. The variant allele was found at a frequency of 0.0000571 in 1,383,780 control chromosomes in the GnomAD database, with no homozygous occurrence. It is difficult to determine the true allele frequency of this variant because it is of type DEL_BIG, and the frequency of such variant types in population databases may be underestimated and unreliable. Variant has been reported in ClinVar as Pathogenic (★★). Variant results in nonsense mediated mRNA decay.

Frequency

Genomes: 𝑓 0.00011 ( 0 hom., cov: 33)
Exomes 𝑓: 0.000051 ( 0 hom. )

Consequence

ECEL1
NM_004826.4 frameshift

Scores

Not classified

Clinical Significance

Pathogenic criteria provided, multiple submitters, no conflicts P:6

Conservation

PhyloP100: 6.70

Publications

3 publications found
Variant links:
Genes affected
ECEL1 (HGNC:3147): (endothelin converting enzyme like 1) This gene encodes a member of the M13 family of endopeptidases. Members of this family are zinc-containing type II integral-membrane proteins that are important regulators of neuropeptide and peptide hormone activity. Mutations in this gene are associated with autosomal recessive distal arthrogryposis, type 5D. This gene has multiple pseudogenes on chromosome 2. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Mar 2014]
ECEL1 Gene-Disease associations (from GenCC):
  • distal arthrogryposis type 5D
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, Orphanet, Labcorp Genetics (formerly Invitae), Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Pathogenic. The variant received 16 ACMG points.

PVS1
Loss of function variant, product undergoes nonsense mediated mRNA decay. LoF is a known mechanism of disease.
PP5
Variant 2-232486498-CAGCCCGGACCGGGCCCCGGTGGCGCTGCGCGCAGCGCCCAACGGGA-C is Pathogenic according to our data. Variant chr2-232486498-CAGCCCGGACCGGGCCCCGGTGGCGCTGCGCGCAGCGCCCAACGGGA-C is described in ClinVar as Pathogenic. ClinVar VariationId is 435024.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ECEL1NM_004826.4 linkc.110_155delTCCCGTTGGGCGCTGCGCGCAGCGCCACCGGGGCCCGGTCCGGGCT p.Phe37CysfsTer151 frameshift_variant Exon 2 of 18 ENST00000304546.6 NP_004817.2 O95672-1A0A6F7YIA8
ECEL1NM_001290787.2 linkc.110_155delTCCCGTTGGGCGCTGCGCGCAGCGCCACCGGGGCCCGGTCCGGGCT p.Phe37CysfsTer151 frameshift_variant Exon 2 of 18 NP_001277716.1 O95672-2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ECEL1ENST00000304546.6 linkc.110_155delTCCCGTTGGGCGCTGCGCGCAGCGCCACCGGGGCCCGGTCCGGGCT p.Phe37CysfsTer151 frameshift_variant Exon 2 of 18 1 NM_004826.4 ENSP00000302051.1 O95672-1
ECEL1ENST00000409941.1 linkc.110_155delTCCCGTTGGGCGCTGCGCGCAGCGCCACCGGGGCCCGGTCCGGGCT p.Phe37CysfsTer151 frameshift_variant Exon 1 of 17 1 ENSP00000386333.1 O95672-2
ECEL1ENST00000482346.1 linkn.314_359delTCCCGTTGGGCGCTGCGCGCAGCGCCACCGGGGCCCGGTCCGGGCT non_coding_transcript_exon_variant Exon 2 of 17 2

Frequencies

GnomAD3 genomes
AF:
0.000106
AC:
16
AN:
151644
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0000725
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000394
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000207
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000737
Gnomad OTH
AF:
0.000479
GnomAD2 exomes
AF:
0.000326
AC:
7
AN:
21450
AF XY:
0.000299
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00195
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000215
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000511
AC:
63
AN:
1232136
Hom.:
0
AF XY:
0.0000431
AC XY:
26
AN XY:
602972
show subpopulations
African (AFR)
AF:
0.0000417
AC:
1
AN:
23970
American (AMR)
AF:
0.000750
AC:
9
AN:
11998
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
18550
East Asian (EAS)
AF:
0.0000367
AC:
1
AN:
27260
South Asian (SAS)
AF:
0.00
AC:
0
AN:
55072
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
29944
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
3548
European-Non Finnish (NFE)
AF:
0.0000494
AC:
50
AN:
1011176
Other (OTH)
AF:
0.0000395
AC:
2
AN:
50618
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.454
Heterozygous variant carriers
0
4
8
13
17
21
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000106
AC:
16
AN:
151644
Hom.:
0
Cov.:
33
AF XY:
0.000162
AC XY:
12
AN XY:
74044
show subpopulations
African (AFR)
AF:
0.0000725
AC:
3
AN:
41368
American (AMR)
AF:
0.000394
AC:
6
AN:
15220
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5136
South Asian (SAS)
AF:
0.000207
AC:
1
AN:
4832
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10426
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
314
European-Non Finnish (NFE)
AF:
0.0000737
AC:
5
AN:
67882
Other (OTH)
AF:
0.000479
AC:
1
AN:
2086
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.431
Heterozygous variant carriers
0
1
3
4
6
7
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000253
Hom.:
0

ClinVar

Significance: Pathogenic
Submissions summary: Pathogenic:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Distal arthrogryposis type 5D Pathogenic:4
Jul 17, 2023
Victorian Clinical Genetics Services, Murdoch Childrens Research Institute
Significance:Pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Based on the classification scheme VCGS_Germline_v1.3.4, this variant is classified as Pathogenic. Following criteria are met: 0102 - Loss of function is a likely mechanism of disease in this gene and is associated with distal arthrogryposis, type 5D (MIM#615065). (I) 0106 - This gene is associated with autosomal recessive disease. (I) 0201 - Variant is predicted to cause nonsense-mediated decay (NMD) and loss of protein (premature termination codon is located at least 54 nucleotides upstream of the final exon-exon junction). (SP) 0251 - This variant is heterozygous. (I) 0304 - Variant is present in gnomAD <0.01 (v3) for a recessive condition (16 heterozygotes, 0 homozygotes). (SP) 0701 - Other null variants comparable to the one identified in this case have very strong previous evidence for pathogenicity. There are multiple NMD-predicted variants that have been classified as likely pathogenic or pathogenic (DECIPHER). (SP) 0801 - This variant has strong previous evidence of pathogenicity in unrelated individuals. This variant has been classified as pathogenic by multiple clinical diagnostic laboratories and has been identified in individuals with distal arthrogryposis (ClinVar; PMIDs: 30792901, 33966749, 33060286). (SP) 1102 - Strong phenotype match for this individual. (SP) 1201 - Heterozygous variant detected in trans with a heterozygous likely pathogenic variant, NM_004826.3(ECEL1):c.1783_1788del, p.(Pro595Asp596del), in a recessive disease. (I) 1206 - This variant has been shown to be paternally inherited (by segregation analysis). (I) Legend: (SP) - Supporting pathogenic, (I) - Information, (SB) - Supporting benign -

May 05, 2016
Genetic Services Laboratory, University of Chicago
Significance:Pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Aug 15, 2019
Genomic Medicine Lab, University of California San Francisco
Significance:Pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Dec 19, 2024
Genomic Medicine Center of Excellence, King Faisal Specialist Hospital and Research Centre
Significance:Pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Inborn genetic diseases Pathogenic:1
Jan 17, 2017
Ambry Genetics
Significance:Pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Pathogenic:1
Jun 03, 2022
GeneDx
Significance:Pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Identified in the presence of a second ECEL1 variant in a patient with arthrogryposis (Scocchia et al., 2019); Frameshift variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss-of-function is a known mechanism of disease; This variant is associated with the following publications: (PMID: 23236030, 23261301, 25099528, 24782201, 25708584, 33743358, 33966749, 30792901, 27535533) -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
PhyloP100
6.7
Mutation Taster
=52/148
disease causing (ClinVar)

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1341894581; hg19: chr2-233351208; COSMIC: COSV107349832; COSMIC: COSV107349832; API